I-mab Biopharma US Limited

Patents = 13

Trademarks = 6

Forward Citations = 8

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

37 inventors (with patents filed for the assignee):

I-Mab Biopharma is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of novel and highly differentiated biologics in immuno-oncology and autoimmune diseases. The company has a diverse pipeline of antibodies and bi-specific antibodies, with several candidates in phase 1 or phase 2 clinical trials. Its mission is to bring transformative medicines to patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com